ATYR
aTYR PHARMA INC
NASDAQ · Healthcare · Biotechnology · US
$6.18
−6.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.42x
- Price / sales
- 3190.42x
- Price / cash flow
- -11.11x
Enterprise value
- Enterprise value
- $559.9M
- EV / sales
- 2946.67x
- EV / EBITDA
- -9.36x
- EV / EBIT
- -8.77x
- Market cap
- $606.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026